Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CMMB | BMY | AMGN | GILD | REGN |
| Company | Chemomab Therapeutics Ltd ADR | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.6700 | 49.29 | 335.15 | 83.26 | 1,145.99 |
| High | 1.7600 | 49.53 | 338.19 | 83.76 | 1,149.42 |
| Low | 1.6600 | 49.06 | 334.27 | 82.75 | 1,141.87 |
| Last | 1.6900 | 49.37 | 337.22 | 83.51 | 1,147.43 |
| Change | +0.0100 | +0.35 | +1.27 | -0.39 | -2.76 |
| % Change | +0.60% | +0.71% | +0.38% | -0.46% | -0.24% |
| Volume | 87,169 | 6,284,066 | 999,387 | 3,399,541 | 143,350 |
| 20-Day Average Volume | 449,013 | 8,407,844 | 1,698,495 | 6,546,233 | 410,864 |
| Previous Close | 1.6800 | 49.02 | 335.95 | 83.90 | 1,150.19 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.9137 | 49.17 | 330.16 | 80.44 | 1,163.31 |
| 20-Day Raw Stochastic | 37.95% | 58.16% | 85.20% | 83.07% | 30.93% |
| 20-Day Relative Strength | 52.47% | 55.41% | 57.74% | 69.18% | 51.23% |
| Weighted Alpha | +73.60 | -10.40 | +27.14 | +17.21 | +39.99 |
| Today's Opinion | 88% Buy | 72% Buy | 96% Buy | 88% Buy | 80% Buy |
| Previous Opinion | 88% Buy | 56% Buy | 96% Buy | 88% Buy | 80% Buy |
| Last Month's Opinion | 96% Buy | 40% Buy | 88% Buy | 56% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.77% since 09/13/24 | +0.43% since 09/13/24 | +1.08% since 09/13/24 | +0.68% since 09/13/24 | -0.85% since 09/13/24 |
| Low | 1.6100 on 09/19/24 | 48.78 on 09/18/24 | 331.00 on 09/18/24 | 82.38 on 09/17/24 | 1,134.59 on 09/17/24 |
| High | 1.8887 on 09/16/24 | 50.41 on 09/17/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 1,165.85 on 09/19/24 |
| 1-Month | |||||
| %Chg | +37.09% since 08/20/24 | +0.73% since 08/20/24 | +2.28% since 08/20/24 | +11.53% since 08/20/24 | -4.08% since 08/20/24 |
| Low | 1.1800 on 08/23/24 | 46.88 on 08/22/24 | 319.00 on 09/06/24 | 74.80 on 08/21/24 | 1,113.24 on 09/11/24 |
| High | 2.5500 on 09/03/24 | 50.75 on 09/04/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
| 3-Month | |||||
| %Chg | +82.78% since 06/20/24 | +20.22% since 06/20/24 | +8.44% since 06/20/24 | +21.73% since 06/20/24 | +9.49% since 06/20/24 |
| Low | 0.8700 on 08/09/24 | 39.35 on 07/05/24 | 306.11 on 07/03/24 | 66.01 on 07/05/24 | 1,011.67 on 07/03/24 |
| High | 2.5500 on 09/03/24 | 51.19 on 07/29/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
| 6-Month | |||||
| %Chg | +115.45% since 03/20/24 | -4.90% since 03/20/24 | +23.07% since 03/20/24 | +12.69% since 03/20/24 | +18.26% since 03/20/24 |
| Low | 0.5790 on 04/17/24 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 875.22 on 04/26/24 |
| High | 2.5500 on 09/03/24 | 54.47 on 03/28/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,564 | 99,368,440 | 180,215,344 | 104,527,072 | 126,734,816 |
| Shares Outstanding, K | 11,050 | 2,027,100 | 536,435 | 1,245,853 | 110,186 |
| Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -24,220,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 0 | 12,201,000,000 | 8,388,000,000 | 6,954,000,000 | 3,547,100,000 |
| Last Quarter Net Income | -3,630,000 | 1,680,000,000 | 746,000,000 | 1,614,000,000 | 1,432,300,000 |
| 60-Month Beta | 0.53 | 0.46 | 0.61 | 0.18 | 0.12 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 08/21/24 | 2.07 on 07/26/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 11.56 on 08/01/24 |
| Latest Earnings Date | 08/21/24 | 10/31/24 | 10/29/24 | 11/05/24 | 11/07/24 |
| Most Recent Dividend | N/A | 0.600 on 07/05/24 | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 10/04/24 | 08/16/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 36.31 | 17.90 | 17.85 | 29.64 |